Cargando…
Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study
BACKGROUND: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder for which no diagnostic tools are currently available. Patients are diagnosed using the Rome IV criteria and subtyped into a diarrhea, constipation, or mixed phenotype based on their dominant stool pattern. A recent de...
Autores principales: | Van Malderen, Kathleen, Hanning, Nikita, Lambrechts, Helen, Haverhals, Tine, Van Marcke, Silke, Ceuleers, Hannah, De Man, Joris G., De Winter, Benedicte Y., Lamote, Kevin, De Schepper, Heiko U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388331/ https://www.ncbi.nlm.nih.gov/pubmed/35991639 http://dx.doi.org/10.3389/fmed.2022.960000 |
Ejemplares similares
-
Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020) -
Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
por: Ceuleers, Hannah, et al.
Publicado: (2016) -
Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review
por: Hanning, Nikita, et al.
Publicado: (2021) -
EP1020: THE PREVALENCE OF GASTROINTESTINAL SYMPTOMS IN ACUTE COVID-19 INFECTION EVALUATED WITH A DIGITAL QUESTIONNAIRE
por: Malderen, Kathleen Van, et al.
Publicado: (2022) -
Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats
por: Hanning, Nikita, et al.
Publicado: (2021)